The overall hypothesis of Project 1 is that in aging females, cardiometabolic disease, due to associated dysfunction of the ubiquitin/proteasome system, disrupts the ability of estrogens to regulate levels of estrogen receptor (ER) ɑ in the hippocampus, regulation that is necessary for midlife estradiol treatment to exert lasting positive impacts on memory during aging.
Hypothesized model by which effects of estrogens on the hippocampus and memory diverge in healthy and unhealthy females. If individuals are healthy when treatment with estrogens is initiated, estrogens can act through a functional ubiquitin / proteasome system to protect hippocampal ERα from degradation. Once elevated levels are achieved, they will persist, creating a positive feedback loop and prolonged enhanced cognition. If individuals are unhealthy when treatment with estrogens is initiated, estrogens are unable to act to protect ERα in the hippocampus from degradation and has no effect on levels of ERα – a critical factor in the ability of estrogens to impact memory. Created with BioRender.com
Aim 1 will determine if individual differences in cardiometabolic health prior to and/or after onset of estradiol treatment are associated with the ability of estradiol to positively impact memory and the hippocampus.
Aim 2 will determine if estradiol effects on the hippocampal memory system in aging females are impacted by obesity and impaired glucose regulation
Aim 3 will determine if effects of estradiol treatment on the hippocampal memory system in aging females are impacted by cardiovascular disease.